PWP
AZN icon

Pursue Wealth Partners’s AstraZeneca AZN Stock Holding History

Pursue Wealth Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-129
Closed -$18.3K – 127
2022
Q1 		$18.3K Buy
+129
New +$15.5K 0.01% 204

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Pursue Wealth Partners's AZN Position: Q2 2022 in Review

Pursue Wealth Partners sold out of AstraZeneca (AZN) in Q2 2022, closing a stake of 129 shares — an estimated $18.3K sold.

Pursue Wealth Partners first reported a position in AZN in Q1 2022 and held it in 1 quarter. The position peaked at $18.3K in Q1 2022. 1,015 funds tracked by Wall St. Rank hold AZN as of Q2 2022.

  • Pursue Wealth Partners reported no remaining AstraZeneca position as of Q2 2022 after selling out during the quarter.
  • Pursue Wealth Partners sold 129 AstraZeneca shares in Q2 2022, an estimated $18.3K.
  • Pursue Wealth Partners first reported a position in AstraZeneca in Q1 2022 and held it in 1 quarter.
  • Pursue Wealth Partners's AstraZeneca position peaked at $18.3K in Q1 2022.
  • 1,015 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2022.

Based on Pursue Wealth Partners's 13F filing for Q2 2022, filed 11 Aug 2022.